Influx Healthtech Limited, established in September 2020, specializes in contract manufacturing for B2B clients in nutraceuticals, cosmetics, and more, providing comprehensive services from product formulation to commercialization.
Influx Healthtech's Board approved the Directors Report for FY26. They've set the 6th Annual General Meeting for September 18, 2026, and appointed M/s. PNK & Co. as Scrutinizer for the meeting.
Influx Healthtech Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for quarter ended on June 30, 2026